| Ytd | 101.99% | |
| 1y | 192.28% |
| Open | 38.31 | Prev Close | 38.54 | Low | 37.89 | High | 38.74 | Mkt Cap | 1.99B |
| Vol | 61.21K | Avg Vol | 898.22K | EPS | 0.84 | P/E | 45.88 | Forward P/E | 94.34 |
| Beta | 2.43 | Short Ratio | 8.60 | Inst. Own | 101.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 25.64 | 200-d Avg | 20.03 | 1yr Est | 33.00 |
Amova Asset Management Americas Inc. raised its holdings in shares of CareDx, Inc. (NASDAQ: CDNA) by
CareDx has a transplant-testing franchise that taps into recurring surveillance demand and has deepe
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The late
CareDx ($CDNA) shares surge 28% as Medicare finalizes continued coverage for its kidney, heart, and
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's
U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company in transplant, special
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine diagno
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnos
CDNA closes its Naveris buyout, adding NavDx and expanding its precision diagnostics reach into high
CareDx has transformed into a focused, high-acuity specialty diagnostics platform, emphasizing repea
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnos
CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
The CEO sold 17,683 shares for a transaction value of approximately ~$425,000 at a weighted average
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
On June 16, 2026, CareDx Inc (CDNA) shares fell by 3.4% to a current price of $23.22. The stock has
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
CareDx NASDAQ: CDNA executives outlined the company's strategy to focus on precision diagnostics, ex
CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcri
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing
CareDx NASDAQ: CDNA executives outlined the company's growth strategy, first-quarter performance and
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading
U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 1
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Thursday's session saw 189 companies set new 52-week lows.
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the co
On Thursday, 1076 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings
Stocks That Hit 52-Week Lows On Thursday